Open access
Open access
Powered by Google Translator Translator

Global & Public Health (all articles)

Alarming COVID variants show vital role of genomic surveillance

17 Jan, 2021 | 22:18h | UTC

Alarming COVID variants show vital role of genomic surveillance – Nature

 

Commentary on Twitter

 

Herd immunity by infection is not an option

17 Jan, 2021 | 22:16h | UTC

Herd immunity by infection is not an option – Science

 

CDC Study: Performance of an antigen-based test for asymptomatic and symptomatic SARS-CoV-2

17 Jan, 2021 | 22:10h | UTC

Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses — Wisconsin, September–October 2020 – CDC Morbidity and Mortality Weekly Report

 

Commentary on Twitter

 

Study: Vaping combined with smoking may be as harmful as smoking cigarettes alone

17 Jan, 2021 | 21:53h | UTC

Association of Cigarette and Electronic Cigarette Use Patterns With Levels of Inflammatory and Oxidative Stress Biomarkers Among US Adults: Population Assessment of Tobacco and Health Study – Circulation

Commentaries: Vaping combined with smoking is likely as harmful as smoking cigarettes alone, study finds – American Heart Association AND CVD Biomarker Levels Up for Dual Use of E-Cigarettes, Cigarettes – Physician’s Weekly

 

[Preprint] Past COVID-19 infection provides some immunity but people may still carry and transmit virus

15 Jan, 2021 | 09:02h | UTC

Past COVID-19 infection provides some immunity but people may still carry and transmit virus – Public Health England

See also: Covid-19: Past infection provides 83% protection for five months but may not stop transmission, study finds – The BMJ AND COVID reinfections are unusual — but could still help the virus to spread – Nature AND COVID-19 infection gives some immunity, but virus can still be spread, study finds – Reuters AND Expert reaction to a preprint from the SIREN study looking at SARS-CoV-2 infection rates in antibody positive healthcare workers – Science Media Centre

 

Perspective: Ivermectin for COVID-19 — Breakthrough Treatment or Hydroxychloroquine Redux?

15 Jan, 2021 | 08:51h | UTC

Ivermectin for COVID-19 — Breakthrough Treatment or Hydroxychloroquine Redux? – HIV and ID Observations

Related video: Ivermectin For COVID-19 | A Doctor Explains – ZDoggMD

 

NIH Guideline Statement: “there are insufficient data to recommend either for or against the use of ivermectin for the treatment of COVID-19”

15 Jan, 2021 | 08:53h | UTC

The COVID-19 Treatment Guidelines Panel’s Statement on the Use of Ivermectin for the Treatment of COVID-19 – National Institutes of Health

 

Covid-19 deaths are the highest they’ve ever been — and the more infectious variants could make things much worse

15 Jan, 2021 | 08:45h | UTC

Covid-19 deaths are the highest they’ve ever been — and the more infectious variants could make things much worse – STAT

 

CoronaVac study in Brazil: Is the vaccine 50%, 78%, or 100% effective?

14 Jan, 2021 | 02:11h | UTC

Third time’s the charm? Brazil scales back efficacy claims for COVID-19 vaccine from China – Science

See also: CoronaVac’s Overall Efficacy in Brazil Measured at 50.4% – Bloomberg

 

Meta-analysis: Saliva vs. nasopharyngeal swabs equally sensitive for Covid-19 diagnosis

14 Jan, 2021 | 02:13h | UTC

The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs: A Systematic Review and Meta-analysis – Annals of Internal Medicine

Commentary: Saliva, Nasopharyngeal Samples Equally Sensitive for SARS-CoV-2 – Physician’s Weekly

 

Commentary on Twitter

https://twitter.com/EricTopol/status/1348758183846703104

 

A guide to vaccinology: from basic principles to new developments

14 Jan, 2021 | 02:09h | UTC

A guide to vaccinology: from basic principles to new developments – Nature Reviews Immunology

 

Pragmatic Recommendations for the Management of COVID-19 in Low- and Middle-Income Countries

14 Jan, 2021 | 02:04h | UTC

 

How COVID unlocked the power of RNA vaccines

14 Jan, 2021 | 02:09h | UTC

How COVID unlocked the power of RNA vaccines – Nature

Commentary: RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics? – Frontiers in Immunology

 

Three studies highlight low COVID risk of in-person school

14 Jan, 2021 | 02:06h | UTC

Three studies highlight low COVID risk of in-person school – CIDRAP

Study 1: Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden – New England Journal of Medicine

Study 2: Incidence and Secondary Transmission of SARS-CoV-2 Infections in Schools – Pediatrics

Study 3: Minimal transmission of SARS-CoV-2 from paediatric COVID-19 cases in primary schools, Norway, August to November 2020 – Eurosurveillance

 

No ICU beds? Expect double the number of Covid-19 deaths

14 Jan, 2021 | 02:05h | UTC

No ICU beds? Expect double the number of Covid-19 deaths. – Vox

 

Study estimates 50% of new SARS-CoV-2 infections have originated from exposure to asymptomatic or pre-symptomatic individuals

14 Jan, 2021 | 02:08h | UTC

SARS-CoV-2 Transmission From People Without COVID-19 Symptoms – JAMA Network Open

Commentary: At least 50% of COVID-19 cases spread from people without symptoms, a new study found – Business Insider AND More than half of Covid-19 infections acquired from asymptomatic carriers – MedicalResearch

 

Commentary on Twitter

https://twitter.com/TennantRuth/status/1348208811039985665

 

Systematic review into city interventions to address obesity

14 Jan, 2021 | 01:50h | UTC

Systematic review into city interventions to address obesity – EClinicalMedicine

 

Global, regional, and national dengue burden from 1990 to 2017: A systematic analysis based on the global burden of disease study 2017

14 Jan, 2021 | 01:48h | UTC

Global, regional, and national dengue burden from 1990 to 2017: A systematic analysis based on the global burden of disease study 2017 – EClinicalMedicine

 

Immunogenicity and safety of fractional doses of yellow fever vaccines: A randomized, double-blind, non-inferiority trial

14 Jan, 2021 | 01:38h | UTC

Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial – The Lancet

Invited commentary: Public health role for fractional dosage of yellow fever vaccine – The Lancet

 

New study highlights cost-effectiveness of bans on pesticides as a suicide prevention strategy

14 Jan, 2021 | 01:35h | UTC

New study highlights cost-effectiveness of bans on pesticides as a suicide prevention strategy – World Health Organization

Original study: The cost-effectiveness of banning highly hazardous pesticides to prevent suicides due to pesticide self-ingestion across 14 countries: an economic modelling study – The Lancet Global Health

 

Short review: How Dangerous are new COVID-19 strains?

13 Jan, 2021 | 02:31h | UTC

How Dangerous Are New COVID-19 Strains? – Council on Foreign Relations

 

Commentary on Twitter

 

Confirmed reinfection with SARS-CoV-2 variant VOC-202012/01

13 Jan, 2021 | 02:30h | UTC

Confirmed Reinfection with SARS-CoV-2 Variant VOC-202012/01 – Clinical Infectious Diseases

 

Commentary on Twitter

 

Masks and face coverings for the lay public: A narrative update

13 Jan, 2021 | 02:23h | UTC

Masks and Face Coverings for the Lay Public: A Narrative Update – Annals of Internal Medicine

Related: Update Alert 4: Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings – Annals of Internal Medicine

 

Commentary on Twitter (thread – click for more)

 

Video (3 min): Which Covid vaccine is better? Pfizer v Oxford v Moderna

13 Jan, 2021 | 02:21h | UTC

Which Covid vaccine is better? Pfizer v Oxford v Moderna – BBC

 

An evidence review of face masks against COVID-19

13 Jan, 2021 | 02:26h | UTC

An evidence review of face masks against COVID-19 – Proceedings of the National Academy of Sciences

 

Commentary on Twitter

https://mobile.twitter.com/jeremyphoward/status/1348771993949151232

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.